Evidence map›Paper›PMID 27503952›Full record

ArticleProtein engineering, design & selection : PEDS2016

An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.

Dennis Bromley, Matthias R Bauer, Alan R Fersht, Valerie Daggett

Open access · bronzeAbstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Effects of ASPP2 on proliferation and apoptosis of malignant spinal tumor cells.International journal of clinical and experimental pathology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dennis BromleyDivision of Biomedical and Health Informatics, Department of Biomedical Informatics and Medical Education, University of Washington, Box SLU-BIME 358047, 850 Republican St, Building C, Seattle, WA 98109-4714, USA.
Matthias R BauerMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Alan R FershtMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Valerie DaggettDivision of Biomedical and Health Informatics, Department of Biomedical Informatics and Medical Education, University of Washington, Box SLU-BIME 358047, 850 Republican St, Building C, Seattle, WA 98109-4714, USA Department of Bioengineering, University of Washington, Box 355013, Seattle, WA 98195-5013, USA daggett@uw.edu.
MRC Laboratory of Molecular Biology · GBUniversity of Washington · US

Funding

University of Washington Biomedical Informatics and Data Science Research Training ProgramT15LM007442 · NLM · UNIVERSITY OF WASHINGTON · PI JOHN H. GENNARI, Andrea L. Hartzler · 2002 to 2026
$19.6M
MOLECULAR DYNAMICS SIMULATIONS OF PROTEIN UNFOLDINGR01GM050789 · NIGMS · UNIVERSITY OF WASHINGTON · PI DAGGETT, VALERIE D · 2000 to 2014
$3.9M
MOLECULAR DYNAMICS SIMULATIONS OF PROTEIN UNFOLDINGR29GM050789 · NIGMS · UNIVERSITY OF WASHINGTON · PI DAGGETT, VALERIE D · 1995 to 1999
–
Medical Research Council MC_EX_G0901534Medical Research Council MC_UP_A024_1010NIGMS NIH HHS R01 GM050789NIGMS NIH HHS R29 GM050789NLM NIH HHS T15 LM007442
6 · The paper itself

Abstract

The p53 tumor suppressor protein performs a critical role in stimulating apoptosis and cell cycle arrest in response to oncogenic stress. The function of p53 can be compromised by mutation, leading to increased risk of cancer; approximately 50% of cancers are associated with mutations in the p53 gene, the majority of which are in the core DNA-binding domain. The Y220C mutation of p53, for example, destabilizes the core domain by 4 kcal/mol, leading to rapid denaturation and aggregation. The associated loss of tumor suppressor functionality is associated with approximately 75 000 new cancer cases every year. Destabilized p53 mutants can be 'rescued' and their function restored; binding of a small molecule into a pocket on the surface of mutant p53 can stabilize its wild-type structure and restore its function. Here, we describe an in silico algorithm for identifying potential rescue pockets, including the algorithm's integration with the Dynameomics molecular dynamics data warehouse and the DIVE visual analytics engine. We discuss the results of the application of the method to the Y220C p53 mutant, entailing finding a putative rescue pocket through MD simulations followed by an in silico search for stabilizing ligands that dock into the putative rescue pocket. The top three compounds from this search were tested experimentally and one of them bound in the pocket, as shown by nuclear magnetic resonance, and weakly stabilized the mutant.

Indexed as

AlgorithmsComputer SimulationMutationDNALigandsMolecular Docking SimulationMolecular Dynamics SimulationProtein DomainsProtein StabilityTemperatureTumor Suppressor Protein p53DNALigandsTumor Suppressor Protein p53cancerdockingdrug designligandpharmacophoresmall-moleculevisual analytics

Identifiers

PMID27503952
PMCPMC5001139
OpenAlexW2504378293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.